Every enterprise leader has seen the pattern: a proof-of-concept AI tool that impresses in the demo and then three months later, it's hemorrhaging accuracy, choking on edge cases, and nobody can ...

And that was also presented at ASH 2025 and also a very, very strong data set. I should mention that BI-1808 that was monotherapy, single-agent therapy. Then, we also started our Phase IIa trial ...

Molson Coors Beverage (NYSE:TAP) was downgraded to Underperform after reporting a weak quarter and ongoing pressure on beer volumes. The company is expanding its Topo Chico Hard Margarita line, aiming ...

Victor Osimhen has admitted that a potential Champions League round-of-16 showdown with Liverpool would feel "like revenge" ...

The Joint Admissions and Matriculation Board (JAMB) finalises automation for candidates ahead of the for the Unified Tertiary ...

Former Texas state Sen. Brian Birdwell is joining Ditlevson before SASC. Birdwell is a 20-year Army veteran who participated ...

Several discoveries have emerged from the commissioning phase of the new Vera C. Rubin Observatory in Chile, serving as an ...

Egetis Therapeutics AB (FRA:P0F) reports a 74% increase in Q4 revenue, driven by Emcitate's commercial success, despite facing lower profit margins and cash flow challenges.

Amy Willer and Alex Stewart discuss the importance of ensuring that your aquatics facility has a certified pool and spa operator on ...

Venezuela’s attorney general has resigned amid a post‑Maduro shakeup and an amnesty rollout that will test the prosecutor’s ...

Rolls-Royce and the U.S. Air Force validated the F130's ability to meet performance requirements for the B-52 missions, getting closer to flight testing. Engine maker Rolls-Royce announced on Feb. 24, ...